630413-89-7

Upstream product

• 420-04-2 CYANAMID 
• 60857-16-1 N-(4-methoxybenzyl)glycine ethyl ester 
• 122-51-0 orthoformic acid triethyl ester 
• 105-36-2 ethyl bromoacetate 

Downstream Products

• 630413-93-3 1-ethyl-3,7-dihydro-7-[(4-methoxyphenyl)methyl]-1H-purine-2,6-dione 
• 731855-22-4 1-tert-butyl-3,7-dihydro-7-[(4-methoxyphenyl)methyl]-1H-purine-2,6-dione 
• 731855-23-5 1-phenyl-3,7-dihydro-7-[(4-methoxyphenyl)methyl]-1H-purine-2,6-dione 
• 1267635-75-5 C₁₅H₁₉N₃O₃ 
• 1267635-76-6 C₂₁H₂₁ClN₄O₅ 
• 1267635-77-7 C₁₉H₁₇ClN₄O₂ 
• 1267635-78-8 C₂₅H₂₁ClN₄O₂ 
• 925443-93-2 7-{[4-(methyloxy)phenyl]methyl}-1-{2-[(phenylmethyl)oxy]phenyl}-3,7-dihydro-1H-purine-2,6-dione 

Relevant academic research and scientific papers

Imidazo-oxazinone compound as well as preparation method and application thereof

The invention provides an imidazo-oxazinone compound as well as a preparation method and application thereof. The imidazo-oxazinone compound has a structure shown in a formula (I). A series of imidazo-oxazinone compounds are synthesized by using a microwa

DERIVATIVES OF 1-PHENYL-1,5-DIHYDRO-BENZO[B] [1.4]DIAZEPINE-2.4-DIONE AS INHIBITORS OF HIV REPLICATION

Compounds of formula (I) wherein m, R1, R2, R3, X and Y are defined herein, are useful as inhibitors of HIV replication.

Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof

A process for preparing xanthine phosphodiesterase V inhibitors, and compounds utilized in said process. The process includes a five-step methodology for efficient synthesis of Compound 5 without intermediate purifications or separations, a dihalogenation step to synthesize Compound 7, and a coupling reaction to produce Compound 9.